Detalles de la búsqueda
1.
Survival outcomes in patients with acute myeloid leukaemia who received subsequent therapy for relapse in QUAZAR AML-001.
Br J Haematol
; 204(3): 877-886, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-37952982
2.
Efficacy and safety of luspatercept versus epoetin alfa in erythropoiesis-stimulating agent-naive, transfusion-dependent, lower-risk myelodysplastic syndromes (COMMANDS): interim analysis of a phase 3, open-label, randomised controlled trial.
Lancet
; 402(10399): 373-385, 2023 07 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-37311468
3.
Oral azacitidine modulates the bone marrow microenvironment in patients with acute myeloid leukaemia in remission: A subanalysis from the QUAZAR AML-001 trial.
Br J Haematol
; 201(6): 1129-1143, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36990798
4.
Venetoclax plus azacitidine compared with intensive chemotherapy as induction for patients with acute myeloid leukemia: retrospective analysis of an electronic medical record database in the United States.
Ann Hematol
; 102(4): 749-754, 2023 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-36732419
5.
Azacitidine maintenance in AML post induction and posttransplant.
Curr Opin Hematol
; 29(2): 84-91, 2022 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35013047
6.
A phase 1 study of the pan-bromodomain and extraterminal inhibitor mivebresib (ABBV-075) alone or in combination with venetoclax in patients with relapsed/refractory acute myeloid leukemia.
Cancer
; 127(16): 2943-2953, 2021 08 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33934351
7.
NCCN Guidelines Insights: Acute Myeloid Leukemia, Version 2.2021.
J Natl Compr Canc Netw
; 19(1): 16-27, 2021 01 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33406488
8.
Clinical practice recommendation on hematopoietic stem cell transplantation for acute myeloid leukemia patients with FLT3-internal tandem duplication: a position statement from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
Haematologica
; 105(6): 1507-1516, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32241850
9.
What are the most promising new agents in myelodysplastic syndromes?
Curr Opin Hematol
; 26(2): 77-87, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30632987
10.
Acute Myeloid Leukemia, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 17(6): 721-749, 2019 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31200351
11.
Lobular neutrophilic panniculitis associated with DNA methyltransferase inhibitors in the treatment of myeloid disease.
J Cutan Pathol
; 46(12): 930-934, 2019 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-31254406
12.
Epigenetics in Cancer: A Hematological Perspective.
PLoS Genet
; 12(10): e1006193, 2016 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-27723796
13.
Allogeneic Hematopoietic Stem Cell Transplantation Following the Use of Hypomethylating Agents among Patients with Relapsed or Refractory AML: Findings from an International Retrospective Study.
Biol Blood Marrow Transplant
; 24(8): 1754-1758, 2018 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-29649620
14.
Protective mitochondrial transfer from bone marrow stromal cells to acute myeloid leukemic cells during chemotherapy.
Blood
; 128(2): 253-64, 2016 07 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-27257182
15.
Survival outcomes with oral azacitidine maintenance in patients with acute myeloid leukemia in remission by receipt of initial chemotherapy: subgroup analyses from the phase III QUAZAR AML-001 trial.
Haematologica
; 108(10): 2820-2825, 2023 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36951156
16.
Correction to: Venetoclax plus azacitidine compared with intensive chemotherapy as induction for patients with acute myeloid leukemia: retrospective analysis of an electronic medical record database in the United States.
Ann Hematol
; 102(8): 2299, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-37341779
17.
Long-term survival with oral azacitidine for patients with acute myeloid leukemia in first remission after chemotherapy: Updated results from the randomized, placebo-controlled, phase 3 QUAZAR AML-001 trial.
Am J Hematol
; 98(4): E84-E87, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36655608
18.
Acquired TET2 mutation in one patient with familial platelet disorder with predisposition to AML led to the development of pre-leukaemic clone resulting in T2-ALL and AML-M0.
J Cell Mol Med
; 21(6): 1237-1242, 2017 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-27997762
19.
Lenalidomide combined with intensive chemotherapy in acute myeloid leukemia and higher-risk myelodysplastic syndrome with 5q deletion. Results of a phase II study by the Groupe Francophone Des Myélodysplasies.
Haematologica
; 102(4): 728-735, 2017 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-28034993
20.
Wide variations in blood product transfusion practices among providers who care for patients with acute leukemia in the United States.
Transfusion
; 57(2): 289-295, 2017 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-27878822